Related Experiment Video
Updated: Jul 15, 2026

Teratoma Generation in the Testis Capsule
Published on: November 7, 2011
Topoisomerase II alpha expression in testicular germ cell tumors
Nikolay D Dimov1, Debra L Zynger, Chuanyan Luan
1Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Objectives:
Inhibitors of topoisomerase II alpha (TopoIIalpha), an enzyme with a crucial role in DNA maintenance, are included in the chemotherapy protocols for testicular germ cell tumors (GCTs). Despite the success of current chemotherapy regimens, a significant number of patients experience relapse. We analyzed TopoIIalpha expression in primary and metastatic testicular GCTs because this enzyme is a target for some antineoplastic agents.
Methods:
Primary GCT specimens from 109 patients, including 57 seminomas and 52 mixed GCTs (41 embryonal carcinomas, 23 yolk sac tumors, 19 seminomas, 8 choriocarcinomas, 17 teratomas with immature elements, and 16 teratomas with mature elements), were obtained from our archives. The metastatic lesions from 11 of the patients with mixed GCTs included seven teratomas with mature components, five embryonal carcinomas, one yolk sac tumor, one choriocarcinoma, and one teratoma with immature components. Representative sections were subjected to immunohistochemistry with monoclonal antibody against TopoIIalpha, and the nuclear staining findings were evaluated.
Results:
Most embryonal carcinoma (100%), yolk sac tumor (95%), seminoma (88%), and choriocarcinoma (62%) components of the GCTs were TopoIIalpha immunoreactive. None of the teratoma specimens with mature elements expressed TopoIIalpha.
Conclusions:
The results of our study have shown that TopoIIalpha is expressed in most seminomas, embryonal carcinomas, yolk sac tumors, and choriocarcinomas, suggesting a possible mechanism of sensitivity of these components to TopoIIalpha inhibitors. Teratomas with mature and immature elements expressed low levels of TopoIIalpha, which might contribute to their chemoresistance. These findings imply that the variable chemoresponsiveness of testicular GCTs could have an underlying molecular basis.
Insights
Topoisomerase II alpha (TopoIIalpha) is expressed in most testicular germ cell tumor (GCT) types, indicating sensitivity to chemotherapy. Mature teratomas show low TopoIIalpha expression, potentially explaining chemoresistance.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Testicular germ cell tumors (GCTs) are treated with chemotherapy targeting DNA maintenance enzymes.
- Relapse occurs in a significant number of patients despite current regimens.
- Topoisomerase II alpha (TopoIIalpha) is a key enzyme in DNA replication and repair, and a target for chemotherapy.
Purpose of the Study:
- To analyze Topoisomerase II alpha (TopoIIalpha) expression in primary and metastatic testicular GCTs.
- To investigate the correlation between TopoIIalpha expression and chemoresponsiveness in GCTs.
Main Methods:
- Immunohistochemistry was used to evaluate TopoIIalpha expression in 109 primary GCT specimens and metastatic lesions.
- Specimens included seminomas and mixed GCTs (embryonal carcinomas, yolk sac tumors, choriocarcinomas, teratomas).
Main Results:
- High TopoIIalpha immunoreactivity was observed in embryonal carcinoma (100%), yolk sac tumor (95%), seminoma (88%), and choriocarcinoma (62%) components.
- Teratoma specimens with mature elements showed no TopoIIalpha expression.
- Teratomas with immature elements expressed low levels of TopoIIalpha.
Conclusions:
- TopoIIalpha expression in GCTs suggests sensitivity to TopoIIalpha inhibitors.
- Low TopoIIalpha levels in mature and immature teratomas may contribute to chemoresistance.
- Variable chemoresponsiveness in testicular GCTs may be linked to underlying molecular differences in TopoIIalpha expression.
Related Concept Videos
Meiosis II
Meiosis II
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Testes: Histology
The spermatogenic cells, responsible for producing sperm, are...
Abnormal Proliferation
